BCM
ARIA

Bayesian Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bayesian Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,600
Closed -$381K – 824
2016
Q4 		$381K Buy
30,600
+17,500
+134% +$211K 0.09% 363
2016
Q3 		$179K Buy
+13,100
New +$132K 0.12% 294

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Bayesian Capital Management's ARIA Position: Q1 2017 in Review

Bayesian Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 30,600 shares — an estimated $381K sold.

Bayesian Capital Management first reported a position in ARIA in Q3 2016 and held it in 2 quarters. The position peaked at $381K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Bayesian Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 30,600 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $381K.
  • Bayesian Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 2 quarters.
  • Bayesian Capital Management's Ariad Pharmaceuticals Inc position peaked at $381K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Bayesian Capital Management's 13F filing for Q1 2017, filed 15 May 2017.